Study of the role of Phospholipid Phosphatase-Related (PLPPR) proteins in extracellular lipid agonist signaling in the nervous system
| dc.contributor.author | Polyzou, Alexandra | en |
| dc.date.accessioned | 2024-07-01T16:28:31Z | |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/38091 | |
| dc.identifier.uri | http://dx.doi.org/10.26268/heal.uoi.17798 | |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
| dc.subject | Phospholipid Phosphatase-Related Proteins | en |
| dc.subject | Lysophosphatidic acid | en |
| dc.title | Study of the role of Phospholipid Phosphatase-Related (PLPPR) proteins in extracellular lipid agonist signaling in the nervous system | en |
| dc.title | Μελέτη του ρόλου των πρωτεϊνών PLPPR (Phospholipid Phosphatase-Related) στη σηματοδότηση εξωκυττάριων λιπιδικών αγωνιστών στο νευρικό σύστημα | el |
| dc.type | doctoralThesis | en |
| heal.abstract | Phospholipid-phosphatase-related proteins (PLPPRs) constitute a five-member family of neuron-enriched, developmentally regulated membrane proteins that regulate glutamatergic synapses, filopodia and branch formation, as well as growth cone navigation. While displaying homology and similar topology to Lipid Phosphate Phosphatases, they lack Lysophosphatidic Acid (LPA) phosphatase activity. Lysophosphatidic acid (LPA) is a bioactive phospholipid that participates in critical processes in neural development and adult brain function and is implicated in various pathophysiological conditions. Alongside its six well characterized receptors, atypical regulators of LPA signaling have also been suggested, including Phospholipid phosphatase-related proteins (PLPPRs). Previous studies have suggested the involvement of PLPPR4 in neuronal LPA signaling via an LPA transporter or scavenger function, but the role of other PLPPRs, including PLPPR3, a close PLPPR4 relative, in LPA signaling, remains elusive. The objectives of this dissertation were to explore the expression of all Plppr family members in distinct brain regions and in different types of neurons throughout development and in adulthood, to study their ability to form complexes, to investigate the functional and structural interactions of PLPPR3 with LPA, and to identify if LPA effects in neuronal morphology are mediated by PLPPR3. Plpprs were found to be differentially expressed in the striatum, the Nucleus accumbens, the Prefrontal cortex and the dorsal and ventral hippocampus of developing animals and their expression is maintained at significant levels during adulthood. They are also expressed in specific developing and adult GABAergic and glutamatergic neuronal types and subcellular fractionation experiments showed that both PLPPR4 and PLPPR3 are co-expressed in adult synaptosomal membranes. Moreover, specific Plpprs may compensate to some extent for Plppr3 in specific brain regions. Additionally, PLPPRs form homomeric and heteromeric complexes in vitro mostly through their transmembrane domains and these complexes are not controlled by LPA. The presence of PLPPR3, PLPPR4 and PLPPR5, increases the ability of HEK293 cells to take up LPA, however a different mechanism of action is suggested for PLPPR3 in neuroblastoma cells that depends on concentration and duration of treatment, as well as on the transcriptomic profile of the cell line. Furthermore, PLPPR3 was found to bind LPA with two different binding affinity constants: one in the low nanomolar range when assessing the full-length PLPPR3 and one in the low micromolar range when assessing PLPPR3-ICD. Finally, it was shown that PLPPR3 mediates complex neuronal LPA responses in early polarized but not in fully polarized neurons, suggesting its involvement as a sensor of LPA in early stages of development, and it influences LPA-related F-actin changes in fully polarized neurons. Overall, our data show that Plpprs are also present in the adult brain and also in the form of complexes and highlight PLPPR3 as a synaptic regulator of LPA signal transduction. | en |
| heal.academicPublisher | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.academicPublisherID | uoi | el |
| heal.access | embargo | el |
| heal.advisorName | Λεονταρίτης, Γεώργιος | el |
| heal.committeeMemberName | Λεονταρίτης, Γεώργιος | el |
| heal.committeeMemberName | Χριστοφορίδης, Σάββας | el |
| heal.committeeMemberName | Eickholt, Britta J. | en |
| heal.committeeMemberName | Αντωνίου, Αικατερίνη | el |
| heal.committeeMemberName | Κωνσταντή, Μαρία | el |
| heal.committeeMemberName | Παππάς, Περικλής | el |
| heal.committeeMemberName | Λαμπρακάκης, Χαράλαμπος | el |
| heal.dateAvailable | 2027-06-30T21:00:00Z | |
| heal.fullTextAvailability | true | |
| heal.language | en | el |
| heal.numberOfPages | 150 | el |
| heal.publicationDate | 2024-05 | |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας | el |
| heal.type | doctoralThesis | el |
| heal.type.el | Διδακτορική διατριβή | el |
| heal.type.en | Doctoral thesis | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 3.22 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: